Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tango Therapeutics (TNGX) Total Non-Current Liabilities: 2020

  • Tango Therapeutics' Total Non-Current Liabilities was N/A to $168.6 million in Q4 2020 from the same period last year, while for Dec 2020 it was $168.6 million, marking a year-over-year change of. This contributed to the annual value of $168.6 million for FY2020, which is N/A change from last year.
  • As of Q4 2020, Tango Therapeutics' Total Non-Current Liabilities stood at $168.6 million.
  • Over the past 5 years, Tango Therapeutics' Total Non-Current Liabilities peaked at $168.6 million during Q4 2020, and registered a low of $168.6 million during Q4 2020.
  • In the last 1 years, Tango Therapeutics' Total Non-Current Liabilities had a median value of $168.6 million in 2020 and averaged $168.6 million.